Elekta to elect a new board member?
This article was originally published in Clinica
Jan Secher has been proposed as a member of Swedish firm Elekta's board. Mr Secher is currently president and CEO of industrial service provider Ferrostaal. He has also been operating partner of US private equity fund Apollo, and CEO of molecular diagnostics firm Clarient and SICPA, a specialist in security inks. Stockholm-based Elekta develops devices to treat cancer and brain disorder, including tools and planning systems for radiation therapy and radiosurgery.